Outcome measures | Screening | Week 0 (baseline) | Week 1 | Week 2 | Week 3 | Week 7 |
---|---|---|---|---|---|---|
Screening test | V | Â | Â | Â | Â | Â |
Sociodemographic characteristics | V | Â | Â | Â | Â | Â |
Randomization | Â | V | Â | Â | Â | Â |
Laboratory test | V | Â | Â | Â | V | Â |
MA treatment | Â | V | V | V | Â | Â |
NSAIDs prescription | Â | V | V | V | Â | Â |
Visual analog scale | V | V | V | V | V | V |
Neck Disability Index | Â | V | V | V | V | V |
EQ-5D questionnaire | Â | V | V | V | V | V |
PGIC scale | Â | Â | V | V | V | V |
Adverse events | Â | V | V | V | V | V |
Credibility assessment | Â | Â | Â | Â | V | Â |
Total safety assessment | Â | Â | Â | Â | V | Â |